MedTrace Logo

A Trial of HRS-7085 Tablets in Patients With Moderate to Severe Active Ulcerative Colitis

NCT07760831 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2026-08-12

No results posted yet for this study

Summary

The study is being conducted to evaluate the safety, tolerability and pharmakokinetics of HRS-7085 in adults.

Conditions

  • Moderate to Severe Ulcerative Colitis

Interventions

DRUG

HRS-7085 tablets

HRS-7085 tablets

DRUG

Placebo

HRS-7085 tablet blank preparation

Sponsors & Collaborators

  • Jiangsu HengRui Medicine Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-31
Primary Completion
2027-04-30
Completion
2027-09-30

Countries

  • Moldova

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07760831 on ClinicalTrials.gov